Archive for June, 2009

The Texas, California, & Florida Attorneys / Lawyers Of The Mulligan Law Firm Are Now Evaluating Nationwide Accutane® Injury Cases

June 2009

 The Mulligan Law Firm is evaluating injuries related to the use of the prescription drug Accutane®.  Accutane ® is a registered trademark of Hoffman – La Roche, Inc.

If you or a loved one knows of someone potentially injured by Accutane®, please contact The Mulligan Law Firm immediately. The Firm is very interested in speaking with you as soon as possible, and evaluating and investigating your potential claim at no cost.

Accutane® is an acne treatment drug. 

Accutane® was pulled from the US market in June, 2009.  It is allegedly associated with several serious side effects including Inflammatory Bowel Disease (IBD), Colitis, and Crohn’s Disease.  If you or a loved one suffered any serious side effects after taking Accutane®, the lawyers at The Mulligan Law Firm would like to speak with you concerning your potential case.  Such investigatory consultations are confidential and free.  

Statutes of limitations require potential plaintiffs to act within established time-frames. Any failure or delay in contacting an attorney may result in a potential claimant losing his or her rights.

Do not delay: contact The Mulligan Law Firm today if you have questions and concerns about alleged injuries from the use of Accutane®.

The Mulligan Law Firm:

Since its formation in 1995, The Mulligan Law Firm has successfully represented thousands of individuals in a wide variety of practice areas in federal and state courts throughout the United States, and has achieved recoveries for its clients exceeding well over $600,000,000.00  (Six Hundred Million) U.S. dollars. The firm obtained an AV rating with Martindale-Hubbell which indicates very high to preeminent legal ability and very high ethical standards as established by confidential opinions from members of the Bar.

For more information on potential alleged Accutane® injuries and The Mulligan Law Firm, please see our website.

The Mulligan Law Firm’s Texas, California, and Florida Lawyers / Attorneys are evaluating nationwide claims involving Accutane® injuries. 

The Mulligan Law Firm represents clients throughout the United States in conjunction with local counsel licensed in other jurisdictions.

Contact:

PATRICK J. MULLIGAN, Attorney, Lawyer*
ERIC W. GRUENWALD, Attorney, Lawyer**
The Mulligan Law Firm
866-529-0001, EXT. 245
214-219-9779, EXT. 245
Email:  help@mulliganlaw.com
For details about our attorneys and areas of practice, see:
http://www.mulliganlaw.com

*   Licensed in Texas & Georgia.
** Licensed in California only.

Asbestos Producing Companies That May Have Set Up Trusts To Provide Settlement Benefits For Those Injured By Asbestos, Including Lung Cancer, Mesothelioma, Etc.

June 2009

If you or a loved one worked around or with products created by any of the following companies, and later developed lung cancer or mesothelioma, we would like to speak with you regarding your legal rights.  The following companies may have entered bankruptcy (often as a result of the number of asbestos-injury claims brought against them) and set up trust accounts to provide settlements / benefits for those injured by Asbestos Products.  In some cases, the year the company declared bankruptcy is listed after the name of the company: 

ABB Lummus Global 2006
A-Best Products 2002
ACandS, Inc. 2002
Amatex Corp. 1982
American Shipbuilding Co. 1993
Ancor Holdings/National Gypsum 1990
API Inc. 2005
A.P. Green Industries, Inc.
A.P. Green International, Inc.
A.P. Green Refractories
A.P. Green Services, Inc.
API Inc. 2005
Armstrong World Industries 2000
Artra Group, Inc. 2002
Asarco, Inc. 2005
Asbestospray
Babcock & Wilcox Co. 2000
Brauer Supply Co. 2005
Brunswick Fabricators 1998
Burns & Roe 2001
Carey Canada, Inc. 1990
Cassiar Mines 1992
Celotex Corp. 1990
C.E. Thurston 2003
Christy Refractories Co. 2008
Combustion Engineering 2003
Congoleum Corp. 2003
Dana Corporation 2006
Delaware Insulations Distributors 1989
Dresser Industries/Halliburton 2003
Eagle Pitcher Industries 1991
Eastco Industrial Safety Corp.
EJ Bartells Co. 2001
Federal Mogul Corp. 2001
Fibreboard Corporation
Flintkote Co. 2004
Forty-Eight Insulations 1985
Fuller-Austin Insulation Co. 1998
Gasket Holdings Inc.
Gatke Corp. 1987
G-I Holdings 2001
GlT 2002
Harbison-Walker Refractories Co. / A.P. Green Ind. / North American 2002
Harnischfeger Corp. 1999
Hercules Chemical Co. 2008
Hillsborough Holdings 1989
H.K. Porter Co. 1991
Insul Co. 2001
Johns-Manville Corp. 1982
JP Stevens 2004
JT Thorpe 2002
Kaiser Aluminum Corp. 2002
Keene Corp. 1993
Kentile Floors Inc. 1992
Lake Asbestos of Quebec 2005
Lloyd E. Mitchell Co. 2006
McLean Industries 1986
M.H. Detrick 1998
Mid-Valley /Halliburton 2003
The Muralo Co. 2003
Murphy Marine Services 2001
National Gypsum (Asbestos Claims Management Corp.)
North American Asbestos
North American Refractories Co. (NARCO) 2002
Nicolet, Inc. 1987
Ogelbay Norton (ONCO) 2004
Owens Corning/Fibreboard 2000
Pacific Insulation Co. 2007
Philadelphia Asbestos Corp. 1986
Pittsburgh Corning 2000
Plibrico Co. 2002
Porter-Hayden Co. 2002
Prudential Lines, Inc. 1986
Quigley Co. 2004
Raymark Corp./Raytech Corp. 1989
Refractories Co.
Rock Wool Manufacturing 1996
Rutland Fire Clay Co. 1999
Schutte & Koerting, Inc.
Southern Textile Corp.
Solutia, Inc.
Spraycraft
Shook & Fletcher Insulation Co. 2002
Skinner Engine Co. 2001
Special Electric Co. 2004
Special Metals Corp. 2002
Standard Insulations, Inc. 1986
Swan Transportation Co. 2001
T&N, Ltd. (part of Federal–Mogul Bankruptcy)
T H Agriculture & Nutrition 2008
Thorpe Insulation Co. 2007
Todd Shipyards 1987
Unarco Industries, Inc. 1982
United States Gypsum Company
United States Lines 1986
United States Mineral Products 2001
UNR Industries, Inc. 1982
USG Corp. 2001
Utex Industries 2004
Wallace & Gale 1984
Washington Group International
Waterman Steamship Corp. 1983
Western Macarthur 2002
W.R. Grace Co. 2001

The Mulligan Law Firm is Evaluating Raptiva® (Efalizumab) Alleged Injury Cases

June 2009

The Mulligan Law Firm is Evaluating Raptiva® (Efalizumab) Alleged Injury Cases

The Mulligan Law Firm announces that it is evaluating and investigating cases where the usage of the drug Raptiva® has allegedly led to a rare brain infection known as Progressive Multifocal Leukoencephalopathy (PML), a very serious and almost always fatal viral brain infection.    

The Mulligan Law Firm (http://www.mulliganlaw.com) is evaluating alleged injuries related to the use of the drug Raptiva®.

If you or a loved one knows of someone potentially injured by Raptiva®, you should contact The Mulligan Law Firm immediately. The firm is very interested in speaking with you, and evaluating and investigating your potential case at no cost to you.

Raptiva is a psoriasis treatment drug.  Various serious side effects have been reported. 

Raptiva was pulled from the US market in April, 2009.  It is associated with Progressive Multifocal Leukoencephalopathy (PML).  If you or a loved one suffered any serious side effects after taking Raptiva, the attorneys / lawyers at The Mulligan Law Firm would like to speak with you concerning your potential case.  Such investigatory consultations are confidential and free of charge.  

Statutes of limitations require potential plaintiffs to act within certain established time-frames. Any failure or delay in contacting an attorney may result in a potential claimant losing his or her rights.

Do not delay: contact The Mulligan Law Firm today if you have questions and concerns about alleged injuries from the use of Raptiva®.

About The Mulligan Law Firm:

The Mulligan Law Firm was formed in 1995. The firm has successfully represented thousands of individuals in a wide variety of practice areas in federal and state courts throughout the United States, and has achieved recoveries for its clients exceeding well over $600,000,000.00  (Six Hundred Million) U.S. dollars. The firm obtained an AV rating with Martindale-Hubbell which indicates very high to preeminent legal ability and very high ethical standards as established by confidential opinions from members of the Bar.

For more information on alleged Raptiva® injuries and The Mulligan Law Firm, see the website: http://www.mulliganlaw.com

The Mulligan Law Firm’s Texas, California, and Florida Lawyers / Attorneys are evaluating nationwide claims. 

The Mulligan Law Firm represents clients throughout the United States in conjunction with local counsel licensed in other jurisdictions.

Contact:

Patrick J. Mulligan, Lawyer / Attorney*
Eric Gruenwald, Lawyer / Attorney**
The Mulligan Law Firm
866-529-0001, EXT. 245
214-219-9779, EXT. 245
Email:  help@mulliganlaw.com
For details about our attorneys and areas of practice, see:
http://www.mulliganlaw.com

*   Licensed in Texas & Georgia.
** Licensed in California only.

The Mulligan Law Firm is Evaluating FLEET® PHOSPHO-SODA® Alleged Injury Cases

June 2009

The Mulligan Law Firm is Evaluating FLEET® PHOSPHO-SODA® Alleged Injury Cases

The Mulligan Law Firm announces that it is evaluating and investigating cases where the usage of FLEET® PHOSPHO-SODA® has allegedly led to acute kidney injuries.    

The Mulligan Law Firm (http://www.mulliganlaw.com) has started evaluating alleged acute kidney injuries related to the use of FLEET® PHOSPHO-SODA®.
On December 11, 2008, the Food & Drug Administration (FDA) stated that it would be adding a Boxed Warning to the prescription Oral Sodium Phosphate (OSP) products Visicol® and OsmoPrep®, to advise people of the potential risk of acute phosphate nephropathy (a type of acute kidney injury).

Patients routinely take OSP products to cleanse the bowel before a colonoscopy (colon examination) and other medical procedures.

The FDA stated it was equally concerned about the possible risks associated with the use of certain OSP products that can be purchased over-the-counter (OTC), including Fleet® Phospho-soda®, when used at higher doses for bowel cleansing. 

The available data did not demonstrate a risk of acute kidney injury when Fleet® Phospho-soda® was used at the lower doses for laxative use. 

However, the FDA added that: … “when used for bowel cleansing, these products have the same risks as prescription OSP products. FDA plans to amend the labeling conditions for OTC OSP products to address this concern with bowel cleansing use. In light of the continued receipt of reports of acute phosphate nephropathy, FDA is recommending that consumers not use over-the-counter OSPs for bowel cleansing.”

On the same day that the FDA released its statement, C.B. Fleet Company – the makers of Fleet® Phospho-Soda® – immediately announced a voluntary recall of the product.

If you or a loved one knows of someone potentially injured by Fleet® Phospho-soda®, you should contact The Mulligan Law Firm immediately. The firm is very interested in speaking with you, and evaluating and investigating your potential case at no cost to you.

The attorneys of The Mulligan Law Firm emphasize that in personal injury cases it is vital that steps are taken to preserve all available evidence, and to allow physicians and/or other expert witnesses to thoroughly evaluate any and all potential injuries.

Moreover, statutes of limitations require potential plaintiffs to act within certain established time-frames. Any failure or delay in contacting an attorney may result in a potential claimant losing his or her rights.

Do not delay: contact The Mulligan Law Firm today if you have questions and concerns about alleged injured from the use of Fleet® Phospho-soda®

About The Mulligan Law Firm:

The Mulligan Law Firm was formed in 1995. The firm has successfully represented thousands of individuals in a wide variety of practice areas in federal and state courts throughout the United States, and has achieved recoveries for its clients exceeding well over $600 million U.S. dollars. The firm obtained an AV rating with Martindale-Hubbell which indicates very high to preeminent legal ability and very high ethical standards as established by confidential opinions from members of the Bar.

For more information on birth defects and SSRI use and The Mulligan Law Firm, see the website: http://www.mulliganlaw.com

The Mulligan Law Firm’s Texas, California, and Florida Lawyers / Attorneys are evaluating nationwide claims. 

The Mulligan Law Firm represents clients throughout the United States in conjunction with local counsel licensed in other jurisdictions.

Contact:

Patrick J. Mulligan, Lawyer / Attorney*
Eric Gruenwald, Lawyer / Attorney**
The Mulligan Law Firm
866-529-0001, EXT. 245
214-219-9779, EXT. 245
Email:  help@mulliganlaw.com
For details about our attorneys and areas of practice, see:
http://www.mulliganlaw.com

*   Licensed in Texas & Georgia.
** Licensed in California only.

The Mulligan Law Firm Is Evaluating Claims Of Birth Defects Potentially Related To SSRI Antidepressant Use During Pregnancy

June 2009

The Mulligan Law Firm is Evaluating SSRI (Prozac®, Zoloft®, Lexapro®, Celexa®, and Paxil®) Birth Defect Injury Cases

The Mulligan Law Firm announces that it is evaluating and investigating cases where the usage of SSRI antidepressants such as Prozac®, Zoloft®, Lexapro®, Celexa®, and Paxil® has allegedly led to serious birth defects.  

Dallas, TX — The Mulligan Law Firm (http://www.mulliganlaw.com) has started evaluating possible birth defect injury claims involving the use if SSRI antidepressants such as Prozac®, Zoloft®, Lexapro®, Celexa®, and Paxil®.

Evidence shows that SSRI antidepressant use during pregnancy is allegedly linked to birth defects such as:

• heart defects
• anencephaly (a brain defect at birth)
• omphacele  (a birth defect in which the infant’s intestine or other
abdominal organs stick out of the belly button)
• PPHN  (Babies with PPHN have high-pressure in the blood vessels of their lungs; and, therefore, are unable to get sufficient oxygen into their bloodstream.)
• other birth defects   

If you or a loved one knows of a baby born with birth defects after the mother took  antidepressants you should contact The Mulligan Law Firm immediately. The firm is very interested in speaking with you, and evaluating and investigating your potential case.

The Mulligan Law Firm is now offering a free evaluation and investigation of potential claims related to mothers and infants whom may have suffered from the tragedy of birth defects following the use of SSRI antidepressants such as Prozac®, Zoloft®, Lexapro®, Celexa®, and Paxil® during pregnancy. 

The attorneys of The Mulligan Law Firm emphasize that in personal injury cases it is vital that steps are taken to preserve all available evidence, and to allow physicians and/or other expert witnesses to thoroughly evaluate any and all potential injuries.

Moreover, statutes of limitations require potential plaintiffs to act within certain established time-frames. Any failure or delay in contacting an attorney may result in a potential claimant losing his or her rights.

Do not delay: contact The Mulligan Law Firm today if you have questions and concerns about birth defects potentially related to the use of SSRI antidepressants such as Prozac®, Zoloft®, Lexapro®, Celexa®,  and Paxil®.

About The Mulligan Law Firm:

The Mulligan Law Firm was formed in 1995. The firm has successfully represented thousands of individuals in a wide variety of practice areas in federal and state courts throughout the United States, and has achieved recoveries for its clients exceeding well over $600 million U.S. dollars. The firm obtained an AV rating with Martindale-Hubbell which indicates very high to preeminent legal ability and very high ethical standards as established by confidential opinions from members of the Bar.

The Mulligan Law Firm would like to hear from you to discuss your potential claim.

For more information on birth defects and SSRI use and The Mulligan Law Firm, see the website: http://www.mulliganlaw.com

The Mulligan Law Firm’s Texas, California, and Florida Lawyers / Attorneys are evauating nationwide claims. 

The Mulligan Law Firm represents clients throughout the United States in conjunction with local counsel licensed in other jurisdictions.

Contact:

Patrick J. Mulligan, Lawyer / Attorney*
Eric Gruenwald, Lawyer / Attorney**
The Mulligan Law Firm
214-219-9779, EXT. 245
866-529-0001, EXT. 245
Email:  help@mulliganlaw.com

For details about our attorneys and areas of practice, see:
http://www.mulliganlaw.com

*   Licensed in Texas & Georgia.
** Licensed in California only.